We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+0.75%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$52.9B
AUM Growth
-$871M
Cap. Flow
-$305M
Cap. Flow %
-0.58%
Top 10 Hldgs %
10.68%
Holding
4,294
New
780
Increased
1,199
Reduced
1,223
Closed
1,034

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$412M
2
PFE icon
Pfizer
PFE
+$283M
3
DVN icon
Devon Energy
DVN
+$194M
4
VLO icon
Valero Energy
VLO
+$187M
5
MO icon
Altria Group
MO
+$174M

Sector Composition

Rank Sector Weight
1 Healthcare 15.04%
2 Energy 12.07%
3 Financials 9.11%
4 Consumer Discretionary 8.85%
5 Industrials 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOT
51
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$150M 0.28%
1,846,144
+847,173
+85% +$70.9M
SHPG
52
DELISTED
Shire pic
SHPG
$150M 0.28%
619,403
-50,277
-8% -$12.5M
SPG icon
53
Simon Property Group
SPG
$70.6B
$143M 0.27%
823,829
+820,652
+25,831% +$151M
DD icon
54
DuPont de Nemours
DD
$18.7B
$142M 0.27%
1,093,730
+304,478
+39% +$39.4M
BMRN icon
55
BioMarin Pharmaceuticals
BMRN
$12.9B
$142M 0.27%
1,035,642
-158,000
-13% -$19.6M
TMUS icon
56
T-Mobile US
TMUS
$196B
$141M 0.27%
3,639,257
+91,326
+3% +$3.27M
DFS
57
DELISTED
Discover Financial Services
DFS
$141M 0.27%
2,444,160
-378,110
-13% -$22.2M
HAL icon
58
Halliburton
HAL
$29.4B
$140M 0.27%
3,260,908
+2,869,976
+734% +$132M
VFC icon
59
VF Corp
VFC
$5.65B
$139M 0.26%
2,123,866
+790,110
+59% +$53.4M
YHOO
60
DELISTED
Yahoo Inc
YHOO
$137M 0.26%
3,487,130
+774,025
+29% +$33.2M
JCI icon
61
Johnson Controls International
JCI
$86.7B
$136M 0.26%
2,630,503
+2,088,761
+386% +$112M
TEVA icon
62
Teva Pharmaceuticals
TEVA
$43.5B
$136M 0.26%
2,307,330
-6,683,437
-74% -$412M
CVS icon
63
CVS Health
CVS
$119B
$136M 0.26%
1,293,315
-728,748
-36% -$74.5M
V icon
64
Visa
V
$693B
$135M 0.25%
2,006,916
-1,778,026
-47% -$120M
RTN
65
DELISTED
Raytheon Company
RTN
$134M 0.25%
1,401,395
+1,335,094
+2,014% +$140M
TCOM icon
66
Trip.com Group
TCOM
$29B
$134M 0.25%
3,677,008
+592,108
+19% +$20.7M
INTU icon
67
Intuit
INTU
$100B
$132M 0.25%
1,305,130
+1,277,232
+4,578% +$130M
NXPI icon
68
NXP Semiconductors
NXPI
$56.9B
$129M 0.24%
1,318,651
+807,789
+158% +$82.8M
PARA
69
DELISTED
Paramount Global Class B
PARA
$129M 0.24%
2,332,837
+1,394,418
+149% +$84.2M
HPQ icon
70
HP
HPQ
$27.2B
$129M 0.24%
9,492,549
+2,745,729
+41% +$40.8M
SBAC icon
71
SBA Communications
SBAC
$19.4B
$127M 0.24%
1,105,211
+517,934
+88% +$60.8M
CRM icon
72
Salesforce
CRM
$171B
$127M 0.24%
1,817,014
+1,253,122
+222% +$89.2M
DYN
73
DELISTED
Dynegy, Inc.
DYN
$126M 0.24%
4,316,292
-1,221,345
-22% -$39.7M
RICE
74
DELISTED
Rice Energy Inc.
RICE
$125M 0.24%
6,000,487
+5,866,131
+4,366% +$133M
HALO icon
75
Halozyme
HALO
$12.3B
$124M 0.23%
5,500,691
+750,563
+16% +$13.2M

Similar funds

Israel Englander's Q2 2015 Portfolio in Review

As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.

  • Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
  • Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
  • Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
  • Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
  • Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
  • Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
  • Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.

Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.